List of Tables
    Table 1. Antineoplastic Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Antineoplastic Drugs Market Trends
    Table 3. Antineoplastic Drugs Market Drivers
    Table 4. Antineoplastic Drugs Market Challenges
    Table 5. Antineoplastic Drugs Market Restraints
    Table 6. Global Antineoplastic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Antineoplastic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Antineoplastic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Antineoplastic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Antineoplastic Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Antineoplastic Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Antineoplastic Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Antineoplastic Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Antineoplastic Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Antineoplastic Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Antineoplastic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Antineoplastic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antineoplastic Drugs as of 2021)
    Table 18. Top Players of Antineoplastic Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Antineoplastic Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Antineoplastic Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Antineoplastic Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Antineoplastic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Antineoplastic Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Antineoplastic Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Antineoplastic Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Antineoplastic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Antineoplastic Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Antineoplastic Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Antineoplastic Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Antineoplastic Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Antineoplastic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Antineoplastic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Antineoplastic Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Antineoplastic Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Antineoplastic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Antineoplastic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Antineoplastic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Antineoplastic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Antineoplastic Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Antineoplastic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Hoffmann-La Roche Corporation Information
    Table 43. Hoffmann-La Roche Description and Business Overview
    Table 44. Hoffmann-La Roche Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Hoffmann-La Roche Antineoplastic Drugs Product
    Table 46. Hoffmann-La Roche Recent Development
    Table 47. Amgen Corporation Information
    Table 48. Amgen Description and Business Overview
    Table 49. Amgen Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Amgen Product
    Table 51. Amgen Recent Development
    Table 52. Bristol-Myers Squibb Corporation Information
    Table 53. Bristol-Myers Squibb Description and Business Overview
    Table 54. Bristol-Myers Squibb Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bristol-Myers Squibb Product
    Table 56. Bristol-Myers Squibb Recent Development
    Table 57. Baxter Healthcare Corporation Information
    Table 58. Baxter Healthcare Description and Business Overview
    Table 59. Baxter Healthcare Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Baxter Healthcare Product
    Table 61. Baxter Healthcare Recent Development
    Table 62. Boehringer Ingelheim Corporation Information
    Table 63. Boehringer Ingelheim Description and Business Overview
    Table 64. Boehringer Ingelheim Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Boehringer Ingelheim Product
    Table 66. Boehringer Ingelheim Recent Development
    Table 67. Aspen Global Corporation Information
    Table 68. Aspen Global Description and Business Overview
    Table 69. Aspen Global Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Aspen Global Product
    Table 71. Aspen Global Recent Development
    Table 72. Bayer AG Corporation Information
    Table 73. Bayer AG Description and Business Overview
    Table 74. Bayer AG Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Bayer AG Product
    Table 76. Bayer AG Recent Development
    Table 77. Teva pharmaceutical Industries Corporation Information
    Table 78. Teva pharmaceutical Industries Description and Business Overview
    Table 79. Teva pharmaceutical Industries Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Teva pharmaceutical Industries Product
    Table 81. Teva pharmaceutical Industries Recent Development
    Table 82. Johnson & Johnson Corporation Information
    Table 83. Johnson & Johnson Description and Business Overview
    Table 84. Johnson & Johnson Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Johnson & Johnson Product
    Table 86. Johnson & Johnson Recent Development
    Table 87. Merc & Co. Corporation Information
    Table 88. Merc & Co. Description and Business Overview
    Table 89. Merc & Co. Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Merc & Co. Product
    Table 91. Merc & Co. Recent Development
    Table 92. Pfize Corporation Information
    Table 93. Pfize Description and Business Overview
    Table 94. Pfize Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Pfize Product
    Table 96. Pfize Recent Development
    Table 97. Accord Healthcare Corporation Information
    Table 98. Accord Healthcare Description and Business Overview
    Table 99. Accord Healthcare Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Accord Healthcare Product
    Table 101. Accord Healthcare Recent Development
    Table 102. Genentech Corporation Information
    Table 103. Genentech Description and Business Overview
    Table 104. Genentech Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Genentech Product
    Table 106. Genentech Recent Development
    Table 107. Lundbeck Corporation Information
    Table 108. Lundbeck Description and Business Overview
    Table 109. Lundbeck Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Lundbeck Product
    Table 111. Lundbeck Recent Development
    Table 112. AbbVie Corporation Information
    Table 113. AbbVie Description and Business Overview
    Table 114. AbbVie Antineoplastic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. AbbVie Product
    Table 116. AbbVie Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Antineoplastic Drugs Customers List
    Table 120. Antineoplastic Drugs Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antineoplastic Drugs Product Picture
    Figure 2. Global Antineoplastic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Antineoplastic Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Antineoplastic Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Antineoplastic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Antineoplastic Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Antineoplastic Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Antineoplastic Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Antineoplastic Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Antineoplastic Drugs Report Years Considered
    Figure 11. Product Picture of Chemotherapeutic Agents
    Figure 12. Product Picture of Biological/Immunotherapeutic Agents
    Figure 13. Product Picture of Personalized Medicine
    Figure 14. Global Antineoplastic Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Antineoplastic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Antineoplastic Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Antineoplastic Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Antineoplastic Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Antineoplastic Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Antineoplastic Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Antineoplastic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Antineoplastic Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Antineoplastic Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Antineoplastic Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Antineoplastic Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Cancer Rehabilitation Centers
    Figure 29. Product Picture of Ambulatory Surgical Centers
    Figure 30. Global Antineoplastic Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Antineoplastic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Antineoplastic Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Antineoplastic Drugs Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Antineoplastic Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Antineoplastic Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Antineoplastic Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Antineoplastic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Antineoplastic Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Antineoplastic Drugs Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Antineoplastic Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Antineoplastic Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Antineoplastic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Antineoplastic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Antineoplastic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Antineoplastic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Antineoplastic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Antineoplastic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Antineoplastic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Antineoplastic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Antineoplastic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Antineoplastic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Antineoplastic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Antineoplastic Drugs Value Chain
    Figure 76. Antineoplastic Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed